CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE

Generic: CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE

Aurohealth LLCManufacturer
ORALRoute
CETIRIZINE HYDROCHLORIDEActive Substance
2023-03-08Original Approval

CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE is FDA application ANDA212409, sponsored by AUROBINDO PHARMA LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
DRUG INEFFECTIVE
361 reports
2
PEMPHIGUS
353 reports
3
ABDOMINAL DISCOMFORT
349 reports
4
RHEUMATOID ARTHRITIS
346 reports
5
PAIN
344 reports
6
SYSTEMIC LUPUS ERYTHEMATOSUS
342 reports
7
ALOPECIA
335 reports
8
MATERNAL EXPOSURE DURING PREGNANCY
325 reports
9
FATIGUE
317 reports
10
GLOSSODYNIA
315 reports